Best In Class

Nurosym is pioneering a new class of technology that uses bioelectrical signals targeted to targeted to the body’s neural circuits, improving health without surgery or drugs. As a clinically focused company founded on science, Nurosym’s primary focus is developing evidence based noninvasive drug-free neuromodulation.

Nurosym at a Glance

Groundbreaking

First CE-Marked non-invasive vagal neuromodulation system

Innovative Investment

$10M invested in clinical research with patented Nurosym technology

Milestone Achievement

Over 3 million treatment sessions successfully completed

Scientific Validation

More than 30 peer-reviewed clinical study publications on Nurosym

Extensive Collaboration

Collaborating with over 60 world-class research partners

Robust Exploration

Over 60 ongoing clinical trials underway

Nurosym Results from 30+ Clinical Trials

Vagus Nerve Activity

61% increase in 5 minutes

Long-Covid Symptoms

Fatigue, Brain Fog, GI Symptoms, Pain

61% improvement

Fatigue

48% improvement

Sleep

19% improvement

Inflammation

78% improvement

Depression Score

45% improvement

Heart Rate Variability

18% increase

POTS Tachycardia

40% improvement

Oxidative Stress

28% reduction

Memory

32% improvement

Reading

29% improvement

Macrocirculation

50% improvement

Microcirculation

39% improvement

Attention Deficiency

11% improvement

Anxiety

35% improvement

Atrial Fibrillation

85% reduction

Heart Muscle Function

19% improvement

GI Symptoms

80% improvement

Results in specific study populations. Individual results may vary.

How does Nurosym Work

The Mechanisms of Nurosym Neuromodulation

Nurosym sends patented electrical impulses to the brain via the Vagus Nerve, with clinical trial results showing:

If you are a healthcare professional and would like to learn more about our clinical studies, science or recommended protocols, apply for our Healthcare Professional Program.

Apply here

Learn more about Nurosym research studies.

Go to parasym.co

Meet the Doctors

Dr. Elisabetta Burchi - Nurosym

Dr. Elisabetta Burchi, MD, MBA

Translational research lead at Parasym

A practicing doctor of psychiatry, Dr Burchi is an expert in neuromodulation with deep research and clinical experience in the field. Dr Burchi also holds an MBA from INSEAD and formerly worked at the Albert Einstein School of Medicine in New York. A leader in patient care, neuroscience research, communication and management. Dr. Burchi is a physician-scientist, working with Parasym in clinical affairs with a track record of publishing in the most important scientific journals such as The Lancet, writing successful grant proposals for the NIH, and leading the production of editorial, clinical, regulatory and promotional material in collaborative multidisciplinary teams. Dr. Burchi has also coordinated clinical trials and implemented a tele-medicine practice which received a certification of excellence among more than 100,000 professionals.